356 related articles for article (PubMed ID: 10370896)
21. [Porphyrin fluorescence in plasma of various types of porphyria].
Gregor A; Kostrzewska E; Tarczyńska-Nosal S; Stachurska H
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):284-6. PubMed ID: 7808953
[TBL] [Abstract][Full Text] [Related]
22. Enzyme defects in hereditary porphyria.
Civin WH; Epstein E
Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietic porphyrias: animal models and update in gene-based therapies.
Richard E; Robert-Richard E; Ged C; Moreau-Gaudry F; de Verneuil H
Curr Gene Ther; 2008 Jun; 8(3):176-86. PubMed ID: 18537592
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
[TBL] [Abstract][Full Text] [Related]
25. The porphyrias: genetic and acquired aspects.
Sassa S
Rinsho Ketsueki; 2001 Apr; 42(4):237-41. PubMed ID: 11400290
[No Abstract] [Full Text] [Related]
26. Porphyrias in Norway.
Mykletun M; Aarsand AK; Støle E; Villanger JH; Tollånes MC; Baravelli C; Sandberg S
Tidsskr Nor Laegeforen; 2014 Apr; 134(8):831-6. PubMed ID: 24780981
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and therapeutic strategies for porphyrias.
Neeleman RA; Wensink D; Wagenmakers MAEM; Mijnhout GS; Friesema ECH; Langendonk JG
Neth J Med; 2020 Jul; 78(4):149-160. PubMed ID: 32641543
[TBL] [Abstract][Full Text] [Related]
28. Porphyrias: animal models and prospects for cellular and gene therapy.
de Verneuil H; Ged C; Boulechfar S; Moreau-Gaudry F
J Bioenerg Biomembr; 1995 Apr; 27(2):239-48. PubMed ID: 7592571
[TBL] [Abstract][Full Text] [Related]
29. Management of acute and cutaneous porphyrias.
Badminton MN; Elder GH
Int J Clin Pract; 2002 May; 56(4):272-8. PubMed ID: 12074210
[TBL] [Abstract][Full Text] [Related]
30. ["Double porphyrias" (a review of the literature and case report)].
Krivosheev BN; Lukina IL; Kovalenko LI; Krivosheev AB
Ter Arkh; 1993; 65(7):54-8. PubMed ID: 8105550
[TBL] [Abstract][Full Text] [Related]
31. The cutaneous porphyrias.
Lim HW; Cohen JL
Semin Cutan Med Surg; 1999 Dec; 18(4):285-92. PubMed ID: 10604794
[TBL] [Abstract][Full Text] [Related]
32. The Porphyrias.
Muschalek W; Hermasch MA; Poblete-Gutiérrez P; Frank J
J Dtsch Dermatol Ges; 2022 Mar; 20(3):316-331. PubMed ID: 35304965
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of the erythropoietic porphyrias.
Murphy GM
Dermatol Ther; 2003; 16(1):57-64. PubMed ID: 12919128
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of dominant expression in porphyria.
Badminton MN; Elder GH
J Inherit Metab Dis; 2005; 28(3):277-86. PubMed ID: 15868463
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of porphyria.
Thadani H; Deacon A; Peters T
BMJ; 2000 Jun; 320(7250):1647-51. PubMed ID: 10856069
[No Abstract] [Full Text] [Related]
36. Porphyria. From Sir Walter Raleigh to molecular biology.
Sarkany RP
Adv Exp Med Biol; 1999; 455():235-41. PubMed ID: 10599349
[TBL] [Abstract][Full Text] [Related]
37. [Liver cirrhosis and chronic hepatic porphyria].
Pätzold K; Hahn L; Lohmann J; Porst H
Z Gastroenterol; 1993 Feb; 31 Suppl 2():114-5. PubMed ID: 7483690
[TBL] [Abstract][Full Text] [Related]
38. Drugs and acute porphyrias: reasons for a hazardous relationship.
Roveri G; Nascimbeni F; Rocchi E; Ventura P
Postgrad Med; 2014 Nov; 126(7):108-20. PubMed ID: 25387219
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis and therapy of porphyria cutanea tarda (chronic hepatic porphyria). Preliminary report].
IPPEN H
Klin Wochenschr; 1960 Jan; 38():89. PubMed ID: 13852960
[No Abstract] [Full Text] [Related]
40. The porphyrias.
Werman HA
Emerg Med Clin North Am; 1989 Nov; 7(4):927-42. PubMed ID: 2680472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
